MedPath

A clinical trial to study effect of topical application of Argyreia Speciosa gel as an adjunct to scaling in gingivitis patients

Phase 4
Completed
Conditions
Health Condition 1: K051- Chronic gingivitis
Registration Number
CTRI/2023/05/052310
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1)Chronic gingivitis patients with a minimum of 16 gradable teeth

2)Systemically healthy patients

3)Patients requiring scaling

4)Both males and females between the age group of 20-60 years with 3mm of probing depth

5)Patient not on systemic antibiotics for the past 3 months

6)No use of anti-inflammatory drug within the past 3 months

7)Availability of the patient for the entire duration of the study

8)Not receiving periodontal treatment within last 6 months

9)Patient should be able to understand and give a written inform consent

Exclusion Criteria

1) Patients with history of deleterious habits (i.e. use of tobacco consumption etc.)

2) Patients with systemic diseases (i.e., diabetes mellitus, cancer, HIV, bone metabolic

diseases).

3) Patients on systemic corticosteroids, immunosuppressive agents, radiation therapy,

and/or chemotherapy prescribed or received within 2 months prior to study entry.

4) Pregnant and/or lactating females.

5) Patients contraindicated for scaling

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in gingival inflammation and plaque formationTimepoint: Baseline to 15 days
Secondary Outcome Measures
NameTimeMethod
-Timepoint: -
© Copyright 2025. All Rights Reserved by MedPath